Insider · CIK 0001542052

Hall Susan

Reports to the SEC for 2 companies · MONTREAL, A8

sec.gov

Transactions

Companies

Filings

CIK

0001542052

Forms 4 and 5

Insider transactions

26 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2016-03-11	Endo International plcF Tax Payment	EVP, CSO, Global Head of R&D	FTax Payment	−626 sh	$41.67	−$26.1K	4,826
2016-02-24	Endo International plcF Tax Payment	EVP, CSO, Global Head of R&D	FTax Payment	−239 sh	$49.85	−$11.9K	3,160
2016-02-23	Endo International plcA Award	EVP, CSO, Global Head of R&D	AAward	+13.3K sh	—	—	27,071
2016-02-23	Endo International plcA Award	EVP, CSO, Global Head of R&D	AAward	+6,665 sh	—	—	14,180
2016-02-23	Endo International plc2015 Stock Incentive Plan Stock Options (NQ)A Award	EVP, CSO, Global Head of R&D	AAward	+22.5K sh	—	—	22,481
2015-11-11	Endo International plcP Purchase	EVP, CSO, Global Head of R&D	PPurchase	+1,000 sh	$55.35	+$55.4K	2,666
2015-11-11	Endo International plcA Award	EVP, CSO, Global Head of R&D	AAward	+1,000 sh	—	—	13,740
2015-03-11	Endo International plcF Tax Payment	EVP, CSO, Global Head of R&D	FTax Payment	−626 sh	$89.44	−$56K	1,666
2015-02-24	Endo International plcA Award	EVP, CSO, Global Head of R&D	AAward	+5,865 sh	—	—	12,740
2015-02-24	Endo International plcA Award	EVP, CSO, Global Head of R&D	AAward	+2,932 sh	—	—	9,807
2015-02-24	Endo International plc2010 Stock Incentive Plan Stock Options (NQ)A Award	EVP, CSO, Global Head of R&D	AAward	+10.8K sh	—	—	10,823
2013-07-26	BHCBausch Health Companies Inc.M Exercise/Conversion	Global Head of R&D	MExercise/Conversion	+5,173 sh	—	—	30,088
2013-07-26	BHCBausch Health Companies Inc.F Tax Payment	Global Head of R&D	FTax Payment	−2,500 sh	—	—	27,588
2013-07-26	BHCBausch Health Companies Inc. · Restricted Share UnitsM Exercise/Conversion	Global Head of R&D	MExercise/Conversion	−5,173 sh	—	—	15,521
2013-05-31	BHCBausch Health Companies Inc.M Exercise/Conversion	Global Head of R&D	MExercise/Conversion	+20.7K sh	—	—	34,118
2013-05-31	BHCBausch Health Companies Inc.F Tax Payment	Global Head of R&D	FTax Payment	−9,203 sh	—	—	24,915
2013-05-31	BHCBausch Health Companies Inc. · Restricted Share UnitsM Exercise/Conversion	Global Head of R&D	MExercise/Conversion	+20.7K sh	—	—	20,694
2012-10-04	BHCBausch Health Companies Inc.F Tax Payment	Global Head of R&D	FTax Payment	−8,672 sh	—	—	13,424
2012-09-26	BHCBausch Health Companies Inc.M Exercise/Conversion	Global Head of R&D	MExercise/Conversion	+20.7K sh	—	—	22,096
2012-09-26	BHCBausch Health Companies Inc. · Restricted Share UnitsM Exercise/Conversion	Global Head of R&D	MExercise/Conversion	+20.7K sh	—	—	20,694
2012-04-12	BHCBausch Health Companies Inc.M Exercise/Conversion	Global Head of R&D	MExercise/Conversion	+2,313 sh	—	—	2,313
2012-04-12	BHCBausch Health Companies Inc.F Tax Payment	Global Head of R&D	FTax Payment	+911 sh	—	—	1,402
2012-04-12	BHCBausch Health Companies Inc. · Restricted Share UnitsM Exercise/Conversion	Global Head of R&D	MExercise/Conversion	+2,313 sh	—	—	0
2012-03-07	BHCBausch Health Companies Inc.A Award	Global Head of R&D	AAward	+16.1K sh	$13.24	+$213K	16,120
2012-03-07	BHCBausch Health Companies Inc.S Sale	Global Head of R&D	SSale	−16.1K sh	$54.50	−$879K	0
2012-03-07	BHCBausch Health Companies Inc. · Non-Qualified Stock Options (right to purchase)M Exercise/Conversion	Global Head of R&D	MExercise/Conversion	+16.1K sh	—	—	32,240

Recent filings

Accepted (ET)
Mar 144
Endo International plc0001209191-16-108192
SEC(opens sec.gov)
Feb 254
Endo International plc0001209191-16-102579
SEC(opens sec.gov)
Nov 124
Endo International plc0001209191-15-079483
SEC(opens sec.gov)
Mar 134
Endo International plc0001209191-15-026196
SEC(opens sec.gov)
Feb 264
Endo International plc0001209191-15-019279
SEC(opens sec.gov)
Jul 304
Valeant Pharmaceuticals International, Inc.0000885590-13-000063
SEC(opens sec.gov)
Jun 44
Valeant Pharmaceuticals International, Inc.0000885590-13-000042
SEC(opens sec.gov)
Oct 44
Hall Susan0000885590-12-000062
SEC(opens sec.gov)
Sep 284
Hall Susan0000885590-12-000057
SEC(opens sec.gov)

Companies

Address

VALEANT PHARMACEUTICALS INTERNATIONAL 4787 LEVY ROAD

MONTREAL, A8, H4R 2P9